Categories
· Health/Science
· Lung Cancer
non-USA, by Country
· UK
|
Jump to full article: The Daily Mail and Mail on Sunday (uk), 2009-11-11
Author: Daily Mail Reporter
Intro: A new lung cancer drug that can cure the deadliest form of the disease is being developed by scientists.
The treatment, which appears to have no side affects, killed all traces of the 'small cell' version of the cancer in more than 50 per cent of the British trials on laboratory mice. It also blocked the cells' ability to resist standard chemotherapy treatment.
A fifth of lung cancer patients have the 'small cell' form, in which the tumours spread so quickly they can rarely be removed. Only 3 per cent of sufferers can expect to survive five years after diagnosis.
Professor Michael Seckl, head of Molecular Oncology and Lung Cancer Research at Imperial College, which led the research, said he hoped to start clinical trials with human patients as early as next year.
Jump to full article » |